6701-13-9

Basic information

• Product Name: 1,10-DECAMETHYLENE GLYCOL DIMETHACRYLATE
• Synonyms: 2-Propenoicacid,2-methyl-,1,10-decanediylester;1,10-DECANEDIOL DIMETHACRYLATE;1,10-DECAMETHYLENE GLYCOL DIMETHACRYLATE;1,10-decanediyl bismethacrylate;Bis(methacrylic acid)1,10-decanediyl ester;Bis(methacrylic acid)decane-1,10-diyl ester;Bismethacrylic acid 1,10-decanediyl ester;Bismethacrylic acid decane-1,10-diyl ester
• CAS NO: 6701-13-9
• Molecular Formula: C18H30O4
• Molecular Weight: 310.43
• EINECS: 229-745-1
• Product Categories: monomer
• Mol File: 6701-13-9.mol

Chemical Properties

• Melting Point: 170℃/2mm
• Boiling Point: 386.9°Cat760mmHg
• Flash Point: 181°C
• Appearance: /
• Density: 0.962
• Vapor Pressure: 3.43E-06mmHg at 25°C
• Refractive Index: n/D1.462
• Storage Temp.: 2-8°C
• Water Solubility: 138.6μg/L at 20.3℃
• CAS DataBase Reference: 1,10-DECAMETHYLENE GLYCOL DIMETHACRYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: 1,10-DECAMETHYLENE GLYCOL DIMETHACRYLATE(6701-13-9)
• EPA Substance Registry System: 1,10-DECAMETHYLENE GLYCOL DIMETHACRYLATE(6701-13-9)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38-52/53-43
• Safety Statements: 26-36/37/39-61-36/37-28
• WGK Germany: 3
• Hazardous Substances Data: 6701-13-9(Hazardous Substances Data)

Usage

Uses

Used in Dental Industry:
1,10-Decamethylene glycol dimethacrylate is used as a monomer for the production of dental materials, specifically for preparing camphorquinone/amine-based adhesives. This monomer contributes to the development of dental materials with improved properties, such as enhanced bonding and durability, making it suitable for various dental applications.

InChI:InChI=1/C18H30O4/c1-15(2)17(19)21-13-11-9-7-5-6-8-10-12-14-22-18(20)16(3)4/h1,3,5-14H2,2,4H3

Upstream product

• 112-47-0 1,10-Decanediol 
• 79-41-4 poly(methacrylic acid) 
• 80-62-6 methacrylic acid methyl ester 
• 53463-68-6 1-bromo-10-decanol 
• 64-17-5 ethanol 
• 1078-61-1 dihydrocaffeic acid 
• 2107-70-2 3,4-methoxycinnamic acid 
• 203571-40-8 3-(3,4-bis-benzyloxy-phenyl)-acrylic acid ethyl ester 
• 501-97-3 4-hydroxyphenylpropionic acid 
• 23795-02-0 3-(4-hydroxy-phenyl)-propionic acid ethyl ester 
• 4046-02-0 ethyl 4-hydroxy-3-methoxycinnamate 

Relevant articles and documents

METHOD FOR PRODUCING (METH)ACRYLATE COMPOUND CONTAINING HYDROXYL GROUP AND METHOD FOR PRODUCING (METH)ACRYLATE COMPOUND CONTAINING PHOSPHORIC ACID GROUP

PROBLEM TO BE SOLVED: To provide a method for producing a (meth)acrylate compound containing a hydroxyl group, which, when producing a (meth)acrylate compound containing a hydroxyl group, can suppress formation of by-products. SOLUTION: Provided is a method for producing a (meth)acrylate compound (A) which is a (meth)acrylate compound containing a hydroxyl group, comprising a step of reacting an alcohol compound containing a halogen atom and a (meth)acrylic acid salt to obtain the (meth)acrylate compound (A). SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT

Chemo- and Regioselective Hydrogenolysis of Diaryl Ether C-O Bonds by a Robust Heterogeneous Ni/C Catalyst: Applications to the Cleavage of Complex Lignin-Related Fragments

We report the chemo- and regioselective hydrogenolysis of the C-O bonds in di-ortho-substituted diaryl ethers under the catalysis of a supported nickel catalyst. The catalyst comprises heterogeneous nickel particles supported on activated carbon and furnishes arenes and phenols in high yields without hydrogenation. The high thermal stability of the embedded metal particles allows C-O bond cleavage to occur in highly substituted diaryl ether units akin to those in lignin. Preliminary mechanistic experiments show that this catalyst undergoes sintering less readily than previously reported catalyst particles that form from a solution of [Ni(cod)2].

COLORED COMPOSITION

The present invention is to provide a colored composition having higher heat resistance compared with conventional colored compositions. The present invention further relates to: “a polymer having a monomer unit derived from a monomer which has (i) a cationic rhodamine derivative having, as an counter anion, an anion including an aryl group having an electron-withdrawing substituent and an anion group and (ii) an ethylenically unsaturated bond”, “a monomer which has (i) a cationic rhodamine derivative having, as an counter anion, an anion including an aryl group having an electron-withdrawing substituent and an anion group and (ii) an ethylenically unsaturated bond”, “a colored composition comprising the above-described polymer or the monomer”, and “a colored composition for a color filter comprising the above-described polymer or the monomer”.

Catechol-based substrates of chalcone synthase as a scaffold for novel inhibitors of PqsD

A new strategy for treating Pseudomonas aeruginosa infections could be disrupting the Pseudomonas Quinolone Signal (PQS) quorum sensing (QS) system. The goal is to impair communication among the cells and, hence, reduce the expression of virulence factors and the formation of biofilms. PqsD is an essential enzyme for the synthesis of PQS and shares some features with chalcone synthase (CHS2), an enzyme expressed in Medicago sativa. Both proteins are quite similar concerning the size of the active site, the catalytic residues and the electrostatic surface potential at the entrance of the substrate tunnel. Hence, we evaluated selected substrates of the vegetable enzyme as potential inhibitors of the bacterial protein. This similarity-guided approach led to the identification of a new class of PqsD inhibitors having a catechol structure as an essential feature for activity, a saturated linker with two or more carbons and an ester moiety bearing bulky substituents. The developed compounds showed PqsD inhibition with IC50 values in the single-digit micromolar range. The binding mode of these compounds was investigated by Surface Plasmon Resonance (SPR) experiments revealing that their interaction with the protein is not influenced by the presence of the anthranilic acid bound to active site cysteine. Importantly, some compounds reduced the signal molecule production in cellulo.

Carbon nanotubes supported tyrosinase in the synthesis of lipophilic hydroxytyrosol and dihydrocaffeoyl catechols with antiviral activity against DNA and RNA viruses

Hydroxytyrosol and dihydrocaffeoyl catechols with lipophilic properties have been synthesized in high yield using tyrosinase immobilized on multi-walled carbon nanotubes by the Layer-by-Layer technique. All synthesized catechols were evaluated against a large panel of DNA and RNA viruses, including Poliovirus type 1, Echovirus type 9, Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), Coxsackievirus type B3 (Cox B3), Adenovirus type 2 and type 5 and Cytomegalovirus (CMV). A significant antiviral activity was observed in the inhibition of HSV-1, HSV-2, Cox B3 and CMV. The mechanism of action of the most active dihydrocaffeoyl derivative was investigated against a model of HSV-1 infection.

Design, synthesis and biological evaluation of small molecular polyphenols as entry inhibitors against H5N1

To find novel compounds against H5N1, three series of known or novel small molecular polyphenols were synthesized and tested in vitro for anti-H5N1 activity. In addition, the preliminary structure-antiviral activity relationships were elaborated. The results showed that some small molecular polyphenols had better anti-H5N1 activity, and could serve as novel virus entry inhibitors against H 5N1, likely targeting to HA2 protein. Noticeably, compound 4a showed the strongest activity against H5N1 among these compounds, and the molecular modeling analysis also suggested that this compound might target to HA2 protein. Therefore, compound 4a is well qualified to serve as a lead compound or scaffold for the further development of H 5N1 entry inhibitor.

Tyrosinase and Layer-by-Layer supported tyrosinases in the synthesis of lipophilic catechols with antiinfluenza activity

Catechol derivatives with lipophilic properties have been selectively synthesized by tyrosinase in high yield avoiding long and tedious protection/deprotection steps usually required in traditional procedures. The synthesis was effective also with immobilized tyrosinase able to perform for more runs. The novel catechols were evaluated against influenza A virus, that continue to represent a severe threat worldwide. A significant antiviral activity was observed in derivatives characterized by antioxidant activity and long carbon alkyl side-chains, suggesting the possibility of a new inhibition mechanism based on both redox and lipophilic properties.

CATECHOL-BASED DERIVATIVES FOR TREATING OR PREVENTING DIABETICS

The present invention provides a catechol-based derivative and a pharmaceutical acceptable salt therefrom and a solvate therefrom. A pharmaceutical composition for preventing or treating diabetics and ischemics, comprising a catechol-based derivative of formula (I) and at least one selected from the group consisting of a pharmaceutical excipient, a diluent and a carrier.

AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME

N-(α-cyanobenzyl)amide compounds represented by the formula (1): wherein R1 represents a hydrogen atom; a halogen atom; a C1-C6 alkyl group optionally substituted with a halogen atom or the like; or the like, R2 represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group or the like, R3 represents a hydrogen atom or the like, R4 represents a C1-C4 alkyl group, a C3-C4 alkenyl group or the like, R5 represents a C1-C4 alkyl group, a C3-C4 alkenyl group, or the like, R6 represents a hydrogen atom or the like, R7 represents a hydrogen atom or the like, R8 represents a hydrogen atom or the like, R9 represents a hydrogen atom or the like, R10 represents a hydrogen atom or the like, R11 represents a hydrogen atom or the like, and R12 represents a hydrogen atom or the like, have excellent control activities against plant diseases.

SELF-ETCHING DENTAL COMPOSITIONS AND METHODS

The present invention is directed to dental compositions that can be used as adhesives for bonding a dental material to a dental structure surface and/or as a dental restorative material. The dental composition is preferably applied to a dental structure surface under conditions effective to etch the dental structure surface.